Predict your next investment

Corporate Venture

See what CB Insights has to offer

Investments

51

Funds

2

About Hana Ventures

Hana Ventures, part of Hana Financial Group, is a corporate venture capital unit focusing on information technology and health care.

Hana Ventures Headquarter Location

South Korea

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Hana Ventures News

S-Alpha Therapeutics Raises $2.7M in Seed Funding

Dec 17, 2020

S-Alpha Therapeutics , a Seoul, South Korea-based digital therapeutics startup, closed a $2.7M USD (3 Billion KRW) seed round of funding. Backers included Hana Ventures, STIC Ventures, AJU IB Investment, SJ Investment Partners, and TONY Investment. The company intends to use funds to execute clinical trials in the US to study their development stage digital therapeutic application intended to treat eye disease. Led by Seung Eun Choi, CEO, and Dr. Myung Joon Kim, Chief Medical Officer, S-Alpha is a digital therapeutics company with platform technologies that enable digital devices to treat different diseases. S-Alpha has a pipeline of products in the areas of ophthalmology, neuropsychiatry, cancer, and immunology. Its lead product, SAT-001, is currently in the process of regulatory submission to start clinical studies in Korea as a therapeutic device for treating eye disease following MFDS’s guidance in June 2020. S-Alpha also completed a successful meeting in July 2020 with the USFDA on developing SAT-001 and is preparing to launch clinical studies in the United States. FinSMEs 16/12/2020

Hana Ventures Investments

51 Investments

Hana Ventures has made 51 investments. Their latest investment was in Wyeth Yerz as part of their Seed VC on September 9, 2021.

CBI Logo

Hana Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/13/2021

Seed VC

Wyeth Yerz

$0.43M

Yes

2

8/4/2021

Series A

S-Alpha Therapeutics

$8.74M

No

3

7/15/2021

Series A - II

Carewith

$3.5M

Yes

2

7/13/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

6/8/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/13/2021

8/4/2021

7/15/2021

7/13/2021

6/8/2021

Round

Seed VC

Series A

Series A - II

Series B

Series A

Company

Wyeth Yerz

S-Alpha Therapeutics

Carewith

Subscribe to see more

Subscribe to see more

Amount

$0.43M

$8.74M

$3.5M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

3

2

10

10

Hana Ventures Fund History

2 Fund Histories

Hana Ventures has 2 funds, including Bio Startup Promotion Strategy Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

9/19/2019

Bio Startup Promotion Strategy Fund

Multi-Stage Venture Capital

$123.6M

1

7/1/2019

Hana Digital Transformation Fund

Subscribe to see more

$99M

10

Closing Date

9/19/2019

7/1/2019

Fund

Bio Startup Promotion Strategy Fund

Hana Digital Transformation Fund

Fund Type

Multi-Stage Venture Capital

Subscribe to see more

Status

Amount

$123.6M

$99M

Sources

1

10

Hana Ventures Team

1 Team Member

Hana Ventures has 1 team member, including current Chief Executive Officer, President, DongHwan Kim.

Name

Work History

Title

Status

DongHwan Kim

Chief Executive Officer, President

Current

Name

DongHwan Kim

Work History

Title

Chief Executive Officer, President

Status

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.